2014 SGI 61st Annual Scientific Meeting


                  March 26 - 29, 2014
                      Florence, Italy

Print Email

 

From the FASEB Washington Update 

FASEB AND THE AMERICAN CANCER SOCIETY BRING RESEARCH FUNDING MESSAGE TO ALABAMA
Posted on: September 19, 2011

 OSTP HOSTS MEETING TO DISCUSS BUDGET OUTLOOK FOR SCIENCE PROGRAMS
Posted on: August 19, 2011

DEBT CEILING LEGISLATION COULD AFFECT FEDERAL SCIENCE AGENCIES
Posted on: August 19, 2011

NIH PREVAILS IN EMBRYONIC STEM CELL APPEAL
Posted on: 05/17/2011
 

The United States Court of Appeals for the D.C. Circuit ruled that the National Institutes of Health (NIH) could continue to fund human embryonic stem cell research (hESC) pending the resolution of a lawsuit in the U.S. District Court for the District of Columbia. The 2-1 decision handed down on April 29, 2011 lifted a preliminary injunction issued by District Court Judge Royce C. Lamberth that had blocked NIH from funding hESC research until Judge Lamberth ruled on whether such support violates federal law.

Plaintiffs James L. Sherley and Theresa Deisher argued that federal support for hESC research violates the Dickey-Wicker amendment, a provision attached annually to the Labor, Health and Human Services appropriations bill, that prohibits research resulting in the destruction of human embryos. They also made the case that NIH’s decision to award hESC grants puts them at a competitive disadvantage in acquiring funding for their work on adult stem cells. The task before the Court of Appeals was not to rule on the merits of the case, but rather to decide if there were grounds to halt NIH funding for hESC research until the District Court issued its final decision.

In overturning the preliminary injunction, the court majority concluded that the plaintiffs were unlikely to succeed on the merits of their case. They stated that Dickey-Wicker is ambiguous and deemed it reasonable for NIH “to have concluded that, although Dickey-Wicker bars funding for the destructive act of deriving an ESC from an embryo, it does not prohibit funding a research project in which an ESC will be used.” The majority also stated that the balance of harms that would result from prohibiting hESC research is in NIH’s favor. A preliminary injunction would impose “certain and substantial” hardships on hESC researchers insofar as it would preclude NIH from funding new hESC projects, bar further disbursements to hESC scientists who have research in progress, result in a loss of investment in project planning and equipment expenditures, and lead to job losses for research staff. In contrast, they noted that it is “uncertain whether invalidating the [NIH stem cell] Guidelines would result in plaintiffs getting any more grant money.” The District Court has yet to rule on the merits of the case. Whichever way the court decides, additional appeals are expected.

 

FASEB WASHINGTON UPDATE - APRIL 8, 2011

September 3, 2010

Inside (The Beltway) Scoop – Jennifer Zeitzer  The relative quiet that blanketed Capitol Hill this month was disrupted on August 23rd by a Federal District Court ruling barring federal funding for human embryonic stem cell research (see related story below). Given that nearly all members of Congress are outside of Washington at the moment, the reaction to the judicial decision was limited to a few comments from key stem cell supporters, and it is not clear what legislators will do once they return to work the week of September 13th. http://opa1.faseb.org/pages/WashingtonUpdate/Sept0310/page1.htm#1

Injunction Bars Federal Funding for Human Embryonic Stem Cell Research 
http://opa1.faseb.org/pages/washingtonupdate/Sept0310/page1.htm#2


FASEB President Discusses NIH Funding For 2012 
http://opa1.faseb.org/pages/WashingtonUpdate/Sept0310/page1.htm#3


FASEB Responds to Senate Introduction of the Great Ape Protection Act  http://opa1.faseb.org/pages/WashingtonUpdate/Sept0310/page2.htm#4

National Science Board Considers NSF Data Policies and Mid-Scale Research  http://opa1.faseb.org/pages/WashingtonUpdate/Sept0310/page2.htm#5
 
SGI SGI 2 21 2010-07-23T15:22:00Z 2010-07-23T15:22:00Z 1 552 3148 ACOG 26 7 3693 12.00 Clean Clean false false false false EN-US X-NONE X-NONE
July 23, 2010

Urge Your Senators to Support $37 Billion for NIH in 2011
Make Your Voice Heard on NIH Funding!

You can submit the FASEB online template using this link. http://capwiz.com/faseb/home/ or you can find your elected official by using the link below, copy and paste the letter template below into your e-mail program and send.

Elected Officials Find elected officials, including the president, members of Congress, and more by clicking on this link: http://capwiz.com/faseb/dbq/officials/

This month, the Senate Appropriations Subcommittee on Labor/Health & Human Services/Education (LHHS) will consider and vote on the preliminary version of the bill that will eventually determine the fiscal year 2011 (Oct. 1, 2010 - Sept. 30, 2011) budget for medical research at the National Institutes of Health (NIH).  FASEB issued its annual funding recommendation in January, urging Congress to increase the budget for NIH to $37 billion next year. This funding level is an important step toward achieving a sustainable and predictable investment in biomedical research.

It is important that your Senators hear from you! Please take action now to let your Senators know that we must continue our investment in research to accelerate the pace of discovery and improve the health of our nation's citizens. Feel free to modify the email letter below to include examples from your own research, home institution, or local economy.

TEMPLATE


Dear Senator Enter Name:

I am writing to urge you to support $37 billion for the National Institutes of Health (NIH) as you consider the Fiscal Year 2011 Labor/Health & Human Services/Education (LHHS) Appropriations bill. This funding level will accelerate and promote discoveries leading to improved health of our nation's citizens and will continue the momentum from the American Recovery and Reinvestment Act (ARRA). We must ensure that NIH has the necessary resources to continue currently supported capacity and maintain valuable research initiatives, including those made possible by ARRA funding.

As a researcher/scientist/professor/etc], I am sincerely grateful for your faith in the research community and your generosity in providing the resources that are essential for progress in science. Thanks to the prior federal investment in NIH, my colleagues and I have made critical advances in understanding basic science, mapped the human genome, saved and improved the lives of millions of Americans and provided doctors with tools to prevent and treat costly diseases. Everyday researchers and scientists are working tirelessly to translate research results into interventions for the most debilitating medical conditions and communicate research findings to patients and their families, health care providers, and the general public. Despite the fragile economy, now is not the time to retreat from our historic commitment to investigation and discovery. We must nurture our research investment to benefit from the knowledge that we have gained and ensure that continued progress is not curtailed.

In closing, I respectfully request that you support a funding level of $37 billion for NIH in the Fiscal Year 2011 LHHS Appropriations bill. NIH needs sustainable and predictable budget growth to achieve the full promise of medical researchto improve the health and longevity of all Americans. I appreciate that the LHHS appropriations bill provides funding for a wide range of critical human service programs and thank R?lE3)?@ tXKAP;PHare increasingly shaped by investments in medical research.

 

 
powered by MemberClicks